title: Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point.
authors.affiliation: Université Paris Descartes, 75006 Paris, France; Vascular and Oncological Interventional Radiology department, Hôpital européen Georges Pompidou, 20, rue Leblanc, 75015 Paris cedex 15, France. Electronic address: marc.sapoval2@egp.aphp.fr.
authors.forename: M
authors.initials: M
authors.lastname: Sapoval
authors.affiliation: Université Paris Descartes, 75006 Paris, France; Hôpital européen Georges-Pompidou, AHT Unit, AP-HP, 20, rue Leblanc, 75015 Paris cedex 15, France.
authors.forename: M
authors.initials: M
authors.lastname: Azizi
mesh_terms: D006801:Humans; D006973:Hypertension / Q000601:surgery*; D016032:Randomized Controlled Trials as Topic; D012077:Renal Artery / Q000294:innervation* / Q000601:surgery*; D013562:Sympathectomy; D017211:Treatment Failure